INCERIFY
Live / Registered — Registered (as of 09 Dec 2025)
What this means for you
Registered since 09 Dec 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 09 Dec 2031: the §8 declaration of use).
Record
- Serial number
- 98534840
- Registration number
- 8055533
- Mark type
- Word mark
- Filed
- 06 May 2024
- Published for opposition
- 07 Jan 2025
- Registered
- 09 Dec 2025
- Next maintenance filing
- §8 declaration of use, due by 09 Dec 2031 (grace period to 09 Jun 2032)
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in oncology
Owner
- AstraZeneca AB, Sodertalje, SE
- AstraZeneca AB, Sodertalje, SE
- AstraZeneca AB, Sodertalje, SE
Prosecution history
- 09 Dec 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Dec 2025 — REGISTERED-PRINCIPAL REGISTER
- 18 Nov 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 13 Aug 2025 — NOTICE OF ALLOWANCE CANCELLED
- 17 Nov 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Aug 2025 — TEAS DELETE 1(B) BASIS RECEIVED
- 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jan 2025 — PUBLISHED FOR OPPOSITION
- 01 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Dec 2024 — ASSIGNED TO LIE
- 31 Oct 2024 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED